UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

Economic evaluation of the cost of different methods of retesting chlamydia positive individuals in England

BMJ open, 2019-03, Vol.9 (3), p.e024828-e024828

2019

Volltextzugriff (PDF)

Cost and cost-effectiveness of an HIV pre-exposure prophylaxis (PrEP) programme for high-risk men who have sex with men in England: results of a static decision analytical model

The Lancet (British edition), 2015-11, Vol.386, p.S16-S16

2015

Volltextzugriff (PDF)

Is the existing evidence about costs for outcomes associated with chlamydia sufficiently robust for economic evaluation of the National Chlamydia Screening Programme in England?

The Lancet (British edition), 2015-11, Vol.386, p.S60-S60

2015

Volltextzugriff (PDF)

OPTIMAL USE OF DONOR FUNDING TO INCENTIVIZE VACCINE RESEARCH & DEVELOPMENT FOR NEGLECTED DISEASES: AN ANALYSIS OF DIFFERENT R&D INCENTIVE MECHANISMS

Journal of public and international affairs (Princeton, N.J.), 2012-04, Vol.23, p.80-108

Koh Jun, Ong

2012

Volltextzugriff (PDF)

Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation

The Lancet infectious diseases, 2018-01, Vol.18 (1), p.85-94

2018

Volltextzugriff (PDF)

Economic evaluation of HIV pre-exposure prophylaxis among men-who-have-sex-with-men in England in 2016

Euro surveillance : bulletin européen sur les maladies transmissibles, 2017-10, Vol.22 (42)

2017

Volltextzugriff (PDF)

Chlamydia sequelae cost estimates used in current economic evaluations: does one-size-fit-all?

Sexually transmitted infections, 2017-02, Vol.93 (1), p.18

2017

Volltextzugriff (PDF)

Preparing for PrEP: estimating the size of the population eligible for HIV pre-exposure prophylaxis among men who have sex with men in England

Sexually transmitted infections, 2019-11, Vol.95 (7), p.484

2019

Volltextzugriff (PDF)

P073 If HIV-PrEP is made available in England, what are the resource implications for GUM clinic service providers?

Sexually transmitted infections, 2016-06, Vol.92 (Suppl 1), p.A44-A44

2016

Volltextzugriff (PDF)

Is Pre-Exposure Prophylaxis for HIV prevention cost-effective in men who have sex with men in the UK? A modelling and health economic evaluation

The Lancet infectious diseases, 2017-10, Vol.18 (1), p.85-94

2017

Volltextzugriff (PDF)

IDENTIFYING AND SELECTING NEW PROCEDURES FOR HEALTH TECHNOLOGY ASSESSMENT: A DECADE OF NICE EXPERIENCE IN THE UNITED KINGDOM

International journal of technology assessment in health care, 2014-10, Vol.30 (4), p.454-460

2014

Volltextzugriff (PDF)

Assessing the influence of health systems on Type 2 Diabetes Mellitus awareness, treatment, adherence, and control: A systematic review

PloS one, 2018-03, Vol.13 (3), p.e0195086-e0195086

2018

Volltextzugriff (PDF)

Paediatric actinomycosis: A 16‐year, single‐institution retrospective review of cases

Journal of paediatrics and child health, 2023-06, Vol.59 (6), p.833-839

2023

Volltextzugriff (PDF)

Epidemiological and Clinical Predictors of COVID-19

Clinical infectious diseases, 2020-07, Vol.71 (15), p.786-792

2020

Volltextzugriff (PDF)

Engineered NS1 for Sensitive, Specific Zika Virus Diagnosis from Patient Serology

Emerging infectious diseases, 2021-05, Vol.27 (5), p.1427-1437

2021

Volltextzugriff (PDF)

Do Slit-Lamp Shields and Face Masks Protect Ophthalmologists amidst COVID-19?

Ophthalmology (Rochester, Minn.), 2020-10, Vol.127 (10), p.1427-1429

2020

Volltextzugriff (PDF)

Normative reference values, determinants and regression equations for the incremental shuttle walk test (ISWT) in healthy Asian population aged 21 to 80 years

PloS one, 2023-09, Vol.18 (9), p.e0291132-e0291132

2023

Volltextzugriff (PDF)

An Optimised Protocol Harnessing Laser Capture Microdissection for Transcriptomic Analysis on Matched Primary and Metastatic Colorectal Tumours

Scientific reports, 2020-01, Vol.10 (1), p.682-682, Article 682

2020

Volltextzugriff (PDF)

Perspectives on Acceptance and Use of a Mobile Health Intervention for the Prevention of Atherosclerotic Cardiovascular Disease in Singapore: Mixed-Methods Study

JMIR mHealth and uHealth, 2019-03, Vol.7 (3), p.e11108-e11108

2019

Volltextzugriff (PDF)

User Preferences and Persona Design for an mHealth Intervention to Support Adherence to Cardiovascular Disease Medication in Singapore: A Multi-Method Study

JMIR mHealth and uHealth, 2019-05, Vol.7 (5), p.e10465-e10465

2019

Volltextzugriff (PDF)

Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis

Digestive diseases and sciences, 2024, Vol.69 (1), p.289-297

2024

Volltextzugriff (PDF)

Real‐world effectiveness of sotrovimab and remdesivir for early treatment of high‐risk hospitalized COVID‐19 patients: A propensity score adjusted retrospective cohort study

Journal of medical virology, 2023-02, Vol.95 (2), p.e28460-n/a

2023

Volltextzugriff (PDF)

TOP-004 Impact of MELD 3.0 on waitlist outcomes of metabolic dysfunction-associated steatohepatitis cirrhosis among liver transplant waitlist registrants

Journal of hepatology, 2024-06, Vol.80, p.S366-S367

2024

Volltextzugriff (PDF)

SAT-256 Liver-related complications are the fastest growing cause of mortality from alcohol consumption: results from the global burden of disease 2019 study

Journal of hepatology, 2024-06, Vol.80, p.S139-S139

2024

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(59)

Publikationsform

Sprache

Englisch
(64)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Economic evaluation of the cost of different methods of retesting chlamydia positive individuals in England

Cost and cost-effectiveness of an HIV pre-exposure prophylaxis (PrEP) programme for high-risk men who have sex with men in England: results of a static decision analytical model

Is the existing evidence about costs for outcomes associated with chlamydia sufficiently robust for economic evaluation of the National Chlamydia Screening Programme in England?

OPTIMAL USE OF DONOR FUNDING TO INCENTIVIZE VACCINE RESEARCH & DEVELOPMENT FOR NEGLECTED DISEASES: AN ANALYSIS OF DIFFERENT R&D INCENTIVE MECHANISMS

Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation

Economic evaluation of HIV pre-exposure prophylaxis among men-who-have-sex-with-men in England in 2016

Chlamydia sequelae cost estimates used in current economic evaluations: does one-size-fit-all?

Preparing for PrEP: estimating the size of the population eligible for HIV pre-exposure prophylaxis among men who have sex with men in England

P073 If HIV-PrEP is made available in England, what are the resource implications for GUM clinic service providers?

Is Pre-Exposure Prophylaxis for HIV prevention cost-effective in men who have sex with men in the UK? A modelling and health economic evaluation

IDENTIFYING AND SELECTING NEW PROCEDURES FOR HEALTH TECHNOLOGY ASSESSMENT: A DECADE OF NICE EXPERIENCE IN THE UNITED KINGDOM

Assessing the influence of health systems on Type 2 Diabetes Mellitus awareness, treatment, adherence, and control: A systematic review

Paediatric actinomycosis: A 16‐year, single‐institution retrospective review of cases

Epidemiological and Clinical Predictors of COVID-19

Engineered NS1 for Sensitive, Specific Zika Virus Diagnosis from Patient Serology

Do Slit-Lamp Shields and Face Masks Protect Ophthalmologists amidst COVID-19?

Normative reference values, determinants and regression equations for the incremental shuttle walk test (ISWT) in healthy Asian population aged 21 to 80 years

An Optimised Protocol Harnessing Laser Capture Microdissection for Transcriptomic Analysis on Matched Primary and Metastatic Colorectal Tumours

Perspectives on Acceptance and Use of a Mobile Health Intervention for the Prevention of Atherosclerotic Cardiovascular Disease in Singapore: Mixed-Methods Study

User Preferences and Persona Design for an mHealth Intervention to Support Adherence to Cardiovascular Disease Medication in Singapore: A Multi-Method Study

SAT-281 Clinical characteristics, surveillance, treatment allocation and outcomes of alcohol-related hepatocellular carcinoma: meta-analysis of 37 studies and 66, 559 patients

Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis

Real‐world effectiveness of sotrovimab and remdesivir for early treatment of high‐risk hospitalized COVID‐19 patients: A propensity score adjusted retrospective cohort study

TOP-004 Impact of MELD 3.0 on waitlist outcomes of metabolic dysfunction-associated steatohepatitis cirrhosis among liver transplant waitlist registrants

SAT-256 Liver-related complications are the fastest growing cause of mortality from alcohol consumption: results from the global burden of disease 2019 study

Suchergebnisse filtern